Adia Nutrition, Inc. (ADIA)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003	FY 2002
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
Unallocated Corporate	2.27K	-	-	-	-
Biolete	3.39K	6.38K	-	-	-
Biolete Growth	-46.82%	-	-	-	-
Adia Med	245.96K	-	-	-	-
Adia Labs	448.89K	-	-	-	-
Total	700.51K	6.38K	-	-	-
Total Growth	10879.75%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2004	FY 2003	FY 2002
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
United States	700.51K	6.38K	-	-	-
United States Growth	10879.75%	-	-	-	-
Total	700.51K	6.38K	-	-	-
Total Growth	10879.75%	-	-	-	-

Source: S&P Global Market Intelligence.